ASENT's goal is to encourage and advance the development of improved therapies for diseases and disorders of the nervous system.


2015 Conference Logo

 ASENT's 17th ANNUAL MEETING

Thank you for attending the 17th Annual Meeting. Keep posted to find more about future Annual meetings.
 Agenda

Take a look at 17th Annual Meeting program agenda.

Featuring Educational Session are:

  • Neuroinflammation
  • Orphan Drug Development
  • Lifestyle as Neurotherapeutics
  • The Popular Pipeline Presentation Session
  • Dinner Symposium on Generic Drugs
  • Special Joint Education Session with ISCTM

 


 

 

Neurotherapeutics® Journal Announcement

We are pleased to announce the new Neurotherapeutics® Impact Factor – 5.904. This Impact Factor places the journal 14th  in Thomson Reuters’ Pharmacology & Pharmacy category (out of 260 journals), 11th in the Clinical Neurology category (out of 191 journals), and 30th in the Neurosciences category (out of 251 journals).  Read more


 Neurotherapeutics Banner

 

 

 

Neurotherapeutics® is the official journal of ASENT published by Springer.